Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: a threat to effective secondary line treatment for rifampicin-resistant leprosy cases.

Autor: Ahuja M; Stanley Browne Laboratory, The Leprosy Mission Community Hospital, New Delhi, India; Department of Biotechnology, GLA University, Mathura, India., Singh I Dr; Stanley Browne Laboratory, The Leprosy Mission Community Hospital, New Delhi, India., Lavania M Dr; Stanley Browne Laboratory, The Leprosy Mission Community Hospital, New Delhi, India; Enteric Viruses Group, Indian Council of Medical Research National Institute of Virology, Pune, India; Formerly at Stanley Browne Laboratory, The Leprosy Mission Community Hospital, New Delhi, India. Electronic address: mallikalavania@gmail.com., Pathak VK; Stanley Browne Laboratory, The Leprosy Mission Community Hospital, New Delhi, India., Darlong J Dr; Stanley Browne Laboratory, The Leprosy Mission Community Hospital, New Delhi, India; The Leprosy Mission Hospital, Purulia, India., Turankar RP Dr; Stanley Browne Laboratory, The Leprosy Mission Community Hospital, New Delhi, India., Hembrom S Dr; The Leprosy Mission Hospital, Purulia, India., Singh SV Dr; Department of Biotechnology, GLA University, Mathura, India., Sengupta U Dr; Stanley Browne Laboratory, The Leprosy Mission Community Hospital, New Delhi, India.

Publikováno v: Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2022 Sep; Vol. 30, pp. 282-285. Date of Electronic Publication: 2022 Jun 15.